152 related articles for article (PubMed ID: 32780957)
1. New Insights into Pheochromocytoma Biology: the Role of the Insulin - Like Growth Factor 1 (IGF1) System.
Pennisi PA; Fernández MC; Martin A
Pediatr Endocrinol Rev; 2020 Aug; 17(4):331-342. PubMed ID: 32780957
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways.
de Cubas AA; Leandro-García LJ; Schiavi F; Mancikova V; Comino-Méndez I; Inglada-Pérez L; Perez-Martinez M; Ibarz N; Ximénez-Embún P; López-Jiménez E; Maliszewska A; Letón R; Gómez Graña A; Bernal C; Alvarez-Escolá C; Rodríguez-Antona C; Opocher G; Muñoz J; Megias D; Cascón A; Robledo M
Endocr Relat Cancer; 2013 Aug; 20(4):477-93. PubMed ID: 23660872
[TBL] [Abstract][Full Text] [Related]
3. Pheochromocytoma and Paraganglioma: From Epidemiology to Clinical Findings.
Aygun N; Uludag M
Sisli Etfal Hastan Tip Bul; 2020; 54(2):159-168. PubMed ID: 32617052
[TBL] [Abstract][Full Text] [Related]
4. Management of pheochromocytomas and paragangliomas: Review of current diagnosis and treatment options.
Eid M; Foukal J; Sochorová D; Tuček Š; Starý K; Kala Z; Mayer J; Němeček R; Trna J; Kunovský L
Cancer Med; 2023 Jul; 12(13):13942-13957. PubMed ID: 37145019
[TBL] [Abstract][Full Text] [Related]
5. Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas.
Welander J; Söderkvist P; Gimm O
Endocr Relat Cancer; 2011 Dec; 18(6):R253-76. PubMed ID: 22041710
[TBL] [Abstract][Full Text] [Related]
6. Malignant pheochromocytomas and paragangliomas: a diagnostic challenge.
Gimm O; DeMicco C; Perren A; Giammarile F; Walz MK; Brunaud L
Langenbecks Arch Surg; 2012 Feb; 397(2):155-77. PubMed ID: 22124609
[TBL] [Abstract][Full Text] [Related]
7. Pheochromocytoma/Paraganglioma: A Poster Child for Cancer Metabolism.
Tevosian SG; Ghayee HK
J Clin Endocrinol Metab; 2018 May; 103(5):1779-1789. PubMed ID: 29409060
[TBL] [Abstract][Full Text] [Related]
8. The genomic landscape of phaeochromocytoma.
Flynn A; Benn D; Clifton-Bligh R; Robinson B; Trainer AH; James P; Hogg A; Waldeck K; George J; Li J; Fox SB; Gill AJ; McArthur G; Hicks RJ; Tothill RW
J Pathol; 2015 May; 236(1):78-89. PubMed ID: 25545346
[TBL] [Abstract][Full Text] [Related]
9. Vascular pattern analysis for the prediction of clinical behaviour in pheochromocytomas and paragangliomas.
Oudijk L; van Nederveen F; Badoual C; Tissier F; Tischler AS; Smid M; Gaal J; Lepoutre-Lussey C; Gimenez-Roqueplo AP; Dinjens WN; Korpershoek E; de Krijger R; Favier J
PLoS One; 2015; 10(3):e0121361. PubMed ID: 25794004
[TBL] [Abstract][Full Text] [Related]
10. Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomas.
Lowery AJ; Walsh S; McDermott EW; Prichard RS
Oncologist; 2013; 18(4):391-407. PubMed ID: 23576482
[TBL] [Abstract][Full Text] [Related]
11. Clinical management of paragangliomas.
Corssmit EP; Romijn JA
Eur J Endocrinol; 2014 Dec; 171(6):R231-43. PubMed ID: 25063320
[TBL] [Abstract][Full Text] [Related]
12. PHOX2B is a Sensitive and Specific Marker for the Histopathological Diagnosis of Pheochromocytoma and Paraganglioma.
Miyauchi M; Akashi T; Furukawa A; Uchida K; Tamura T; Ando N; Kirimura S; Shintaku H; Yamamoto K; Ito T; Miura K; Kayamori K; Ariizumi Y; Asakage T; Kudo A; Tanabe M; Fujii Y; Ishibashi H; Okubo K; Murakami M; Yamada T; Takemoto A; Bae Y; Eishi Y; Ohashi K
Endocr Pathol; 2022 Dec; 33(4):506-518. PubMed ID: 36029394
[TBL] [Abstract][Full Text] [Related]
13. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes.
Gimenez-Roqueplo AP; Dahia PL; Robledo M
Horm Metab Res; 2012 May; 44(5):328-33. PubMed ID: 22328163
[TBL] [Abstract][Full Text] [Related]
14. Pheochromocytoma and paraganglioma: germline genetics and hereditary syndromes.
Turin CG; Crenshaw MM; Fishbein L
Endocr Oncol; 2022 Jan; 2(1):R65-R77. PubMed ID: 37435466
[TBL] [Abstract][Full Text] [Related]
15. Genetics and imaging of pheochromocytomas and paragangliomas: current update.
Katabathina VS; Rajebi H; Chen M; Restrepo CS; Salman U; Vikram R; Menias CO; Prasad SR
Abdom Radiol (NY); 2020 Apr; 45(4):928-944. PubMed ID: 31069476
[TBL] [Abstract][Full Text] [Related]
16. Cancer Stem Cells in Pheochromocytoma and Paraganglioma.
Scriba LD; Bornstein SR; Santambrogio A; Mueller G; Huebner A; Hauer J; Schedl A; Wielockx B; Eisenhofer G; Andoniadou CL; Steenblock C
Front Endocrinol (Lausanne); 2020; 11():79. PubMed ID: 32158431
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients.
Currás-Freixes M; Inglada-Pérez L; Mancikova V; Montero-Conde C; Letón R; Comino-Méndez I; Apellániz-Ruiz M; Sánchez-Barroso L; Aguirre Sánchez-Covisa M; Alcázar V; Aller J; Álvarez-Escolá C; Andía-Melero VM; Azriel-Mira S; Calatayud-Gutiérrez M; Díaz JÁ; Díez-Hernández A; Lamas-Oliveira C; Marazuela M; Matias-Guiu X; Meoro-Avilés A; Patiño-García A; Pedrinaci S; Riesco-Eizaguirre G; Sábado-Álvarez C; Sáez-Villaverde R; Sainz de Los Terreros A; Sanz Guadarrama Ó; Sastre-Marcos J; Scolá-Yurrita B; Segura-Huerta Á; Serrano-Corredor Mde L; Villar-Vicente MR; Rodríguez-Antona C; Korpershoek E; Cascón A; Robledo M
J Med Genet; 2015 Oct; 52(10):647-56. PubMed ID: 26269449
[TBL] [Abstract][Full Text] [Related]
18. Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and Imaging.
Alrezk R; Suarez A; Tena I; Pacak K
Front Endocrinol (Lausanne); 2018; 9():515. PubMed ID: 30538672
[TBL] [Abstract][Full Text] [Related]
19. Genetic analyses of apparently sporadic pheochromocytomas: the Rotterdam experience.
Korpershoek E; Van Nederveen FH; Dannenberg H; Petri BJ; Komminoth P; Perren A; Lenders JW; Verhofstad AA; De Herder WW; De Krijger RR; Dinjens WN
Ann N Y Acad Sci; 2006 Aug; 1073():138-48. PubMed ID: 17102080
[TBL] [Abstract][Full Text] [Related]
20. Temozolomide treatment of a malignant pheochromocytoma and an unresectable MAX-related paraganglioma.
Ferrara AM; Lombardi G; Pambuku A; Meringolo D; Bertorelle R; Nardin M; Schiavi F; Iacobone M; Opocher G; Zagonel V; Zovato S
Anticancer Drugs; 2018 Jan; 29(1):102-105. PubMed ID: 29099418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
